These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10733741)

  • 41. Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan-associated protein.
    Kemp M; Kurtzhals JA; Christensen CB; Kharazmi A; Jardim A; Bendtzen K; Gachihi GS; Olafson RW; Theander TG
    Immunol Lett; 1993 Oct; 38(2):137-44. PubMed ID: 8294141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.
    Da-Cruz AM; Bittar R; Mattos M; Oliveira-Neto MP; Nogueira R; Pinho-Ribeiro V; Azeredo-Coutinho RB; Coutinho SG
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):251-6. PubMed ID: 11874860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.
    Carvalho EM; Bacellar O; Brownell C; Regis T; Coffman RL; Reed SG
    J Immunol; 1994 Jun; 152(12):5949-56. PubMed ID: 8207220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxicity in human mucosal and cutaneous leishmaniasis.
    Barral-Netto M; Barral A; Brodskyn C; Carvalho EM; Reed SG
    Parasite Immunol; 1995 Jan; 17(1):21-8. PubMed ID: 7731732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.
    Stäger S; Smith DF; Kaye PM
    J Immunol; 2000 Dec; 165(12):7064-71. PubMed ID: 11120835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunotherapy for visceral leishmaniasis: ability of factors produced during anti-leishmania responses of skin test positive adults to inhibit peripheral blood mononuclear cell activities associated with visceral leishmaniasis.
    Holaday BJ
    Mem Inst Oswaldo Cruz; 1999; 94(1):55-66. PubMed ID: 10029912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production.
    Meyaard L; Hovenkamp E; Keet IP; Hooibrink B; de Jong IH; Otto SA; Miedema F
    J Immunol; 1996 Sep; 157(6):2712-8. PubMed ID: 8805678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization.
    Lees CJ; Apostolopoulos V; McKenzie IF
    J Interferon Cytokine Res; 1999 Dec; 19(12):1373-9. PubMed ID: 10638706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison.
    Kumar A; McElhaney JE; Walrond L; Cyr TD; Merani S; Kollmann TR; Halperin SA; Scheifele DW
    Hum Vaccin Immunother; 2017 Sep; 13(9):2048-2057. PubMed ID: 28635557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.
    Sabur A; Bhowmick S; Chhajer R; Ejazi SA; Didwania N; Asad M; Bhattacharyya A; Sinha U; Ali N
    Front Immunol; 2018; 9():18. PubMed ID: 29441060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV.
    Takele Y; Mulaw T; Adem E; Shaw CJ; Franssen SU; Womersley R; Kaforou M; Taylor GP; Levin M; Müller I; Cotton JA; Kropf P
    Cell Rep Med; 2022 Jan; 3(1):100487. PubMed ID: 35106507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Whole blood assay and visceral leishmaniasis: Challenges and promises.
    Singh OP; Sundar S
    Immunobiology; 2014 Apr; 219(4):323-8. PubMed ID: 24571797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
    Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
    J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
    Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
    Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD8 T cell clones inhibit antitumor T cell function by secreting IL-10.
    Rohrer JW; Coggin JH
    J Immunol; 1995 Dec; 155(12):5719-27. PubMed ID: 7499859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure.
    Brelaz-de-Castro MC; de Almeida AF; de Oliveira AP; de Assis-Souza M; da Rocha LF; Pereira VR
    Cell Immunol; 2012 Oct; 279(2):180-6. PubMed ID: 23246680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human cellular immune response to the saliva of Phlebotomus papatasi is mediated by IL-10-producing CD8+ T cells and Th1-polarized CD4+ lymphocytes.
    Abdeladhim M; Ben Ahmed M; Marzouki S; Belhadj Hmida N; Boussoffara T; Belhaj Hamida N; Ben Salah A; Louzir H
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1345. PubMed ID: 21991402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE.
    Bahrenscheer J; Kemp M; Kurtzhals JA; Gachihi GS; Kharazmi A; Theander TG
    APMIS; 1995 Feb; 103(2):131-9. PubMed ID: 7748537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis.
    Portela ÁSB; Costa LE; Salles BCS; Lima MP; Santos TTO; Ramos FF; Lage DP; Martins VT; Caligiorne RB; Lessa DR; Silva FR; Machado AS; Nascimento GF; Gama IS; Chávez-Fumagalli MA; Teixeira AL; Rocha MOC; Rocha RL; Coelho EAF
    Immunobiology; 2018 Mar; 223(3):303-309. PubMed ID: 29074301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.